Furthermore, blocking transforming growth factor-β (TGF-β) signaling in mice leads to a substantial influx of CD11b+/Ly6G+ neutrophils, which significantly decelerates tumor growth through CD8+ T-cell activation [39]. This evidence concerns the gene ITGAM and neoplasm.